230 related articles for article (PubMed ID: 38281906)
21. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial.
Abt D; Hechelhammer L; Müllhaupt G; Markart S; Güsewell S; Kessler TM; Schmid HP; Engeler DS; Mordasini L
BMJ; 2018 Jun; 361():k2338. PubMed ID: 29921613
[TBL] [Abstract][Full Text] [Related]
22. Prostatic arterial embolisation for men with benign prostatic hyperplasia: a Cochrane review.
Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Kim MH; Narayan V; Dahm P
BJU Int; 2023 Jan; 131(1):32-45. PubMed ID: 35696302
[TBL] [Abstract][Full Text] [Related]
23. Prostatic Artery Embolization Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Cost-Effectiveness Analysis.
Wu X; Zhou A; Heller M; Kohlbrenner R
J Vasc Interv Radiol; 2022 Dec; 33(12):1605-1615. PubMed ID: 35964881
[TBL] [Abstract][Full Text] [Related]
24. Cost-Utility Analysis of Prostatic Artery Embolization for Treatment of Lower Urinary Tract Symptoms.
Capdevila F; Insausti I; San Miguel R; Sanchez-Iriso E; Montesino M
Cardiovasc Intervent Radiol; 2023 Aug; 46(8):1025-1035. PubMed ID: 37142802
[TBL] [Abstract][Full Text] [Related]
25. Minimally Invasive Treatments for Benign Prostatic Obstruction: A Systematic Review and Network Meta-analysis.
Cornu JN; Zantek P; Burtt G; Martin C; Martin A; Springate C; Chughtai B
Eur Urol; 2023 Jun; 83(6):534-547. PubMed ID: 36964042
[TBL] [Abstract][Full Text] [Related]
26. Retrospective observation of the efficacy and safety of prostatic artery embolization combined with transurethral resection of the prostate and simple transurethral resection of the prostate in the treatment of large (> 100 mL) benign prostatic hyperplasia.
Tang Y; Wang RL; Ruan DD; Chen X; Zhou YF; Wu SJ; Cai SL; Zhang JH; Yang FG; Luo JW; Fang ZT
Abdom Radiol (NY); 2021 Dec; 46(12):5746-5757. PubMed ID: 34448024
[TBL] [Abstract][Full Text] [Related]
27. Prostatic Arterial Embolization for Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement.
Curtin P; Chang C; Uflacker A
Curr Urol Rep; 2023 Sep; 24(9):427-441. PubMed ID: 37314610
[TBL] [Abstract][Full Text] [Related]
28. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update.
Cornu JN; Ahyai S; Bachmann A; de la Rosette J; Gilling P; Gratzke C; McVary K; Novara G; Woo H; Madersbacher S
Eur Urol; 2015 Jun; 67(6):1066-1096. PubMed ID: 24972732
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Minimally Invasive Procedures for Benign Prostatic Hyperplasia: A Cost-effectiveness Analysis.
Wu X; Zhou A; Heller M; Chi T; Kohlbrenner R
Radiology; 2023 Dec; 309(3):e230555. PubMed ID: 38085076
[TBL] [Abstract][Full Text] [Related]
30. Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH; Reddy B; McCutcheon KA; Borofsky M; Narayan V; Kim MH; Dahm P
Cochrane Database Syst Rev; 2019 May; 5(5):CD012832. PubMed ID: 31128077
[TBL] [Abstract][Full Text] [Related]
31. Prostatic artery embolization versus conventional TUR-P in the treatment of benign prostatic hyperplasia: protocol for a prospective randomized non-inferiority trial.
Abt D; Mordasini L; Hechelhammer L; Kessler TM; Schmid HP; Engeler DS
BMC Urol; 2014 Nov; 14():94. PubMed ID: 25425136
[TBL] [Abstract][Full Text] [Related]
32. Cost Analysis of Prostate Artery Embolization (PAE) and Transurethral Resection of the Prostate (TURP) in the Treatment of Benign Prostatic Hyperplasia.
Bagla S; Smirniotopoulos J; Orlando J; Piechowiak R
Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1694-1697. PubMed ID: 28560549
[TBL] [Abstract][Full Text] [Related]
33. Prostatic Artery Embolization Allows to Maintain Full Sexual Activity in Patients Suffering from Bothersome Lower Urinary Tracts Symptoms related to Benign Prostatic Hyperplasia.
Marzano L; Thiounn N; Pereira H; Pellerin O; Dariane C; Del Giudice C; Amouyal G; Dean C; Sapoval M
Cardiovasc Intervent Radiol; 2020 Aug; 43(8):1202-1207. PubMed ID: 32494835
[TBL] [Abstract][Full Text] [Related]
34. Introduction of prostate artery embolization (PAE) in Sweden.
Lindgren H; Bläckberg M
Scand J Urol; 2019; 53(2-3):151-155. PubMed ID: 31096824
[No Abstract] [Full Text] [Related]
35. Prostate Artery Embolization as a New Treatment for Benign Prostate Hyperplasia: Contemporary Status in 2016.
Noor A; Fischman AM
Curr Urol Rep; 2016 Jul; 17(7):51. PubMed ID: 27146488
[TBL] [Abstract][Full Text] [Related]
36. Prostatic Artery Embolization (PAE) and Transurethral Resection of the Prostate (TURP) have a Differential Impact on Lower Urinary Tract Symptoms (LUTS): Retrospective Analysis of the Multicentre UK-ROPE (UK Register of Prostate Embolization) Study.
Vigneswaran G; Maclean D; Hadi M; Maher B; Modi S; Bryant T; Harris M; Hacking N
Cardiovasc Intervent Radiol; 2021 Jul; 44(7):1095-1102. PubMed ID: 33825062
[TBL] [Abstract][Full Text] [Related]
37. Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate--a prospective, randomized, and controlled clinical trial.
Gao YA; Huang Y; Zhang R; Yang YD; Zhang Q; Hou M; Wang Y
Radiology; 2014 Mar; 270(3):920-8. PubMed ID: 24475799
[TBL] [Abstract][Full Text] [Related]
38. Prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: A systematic review and meta-analysis.
Wang XY; Chai YM; Huang WH; Zhang Y
World J Clin Cases; 2022 Nov; 10(32):11812-11826. PubMed ID: 36405270
[TBL] [Abstract][Full Text] [Related]
39. Emerging, newly-approved treatments for lower urinary tract symptoms secondary to benign prostatic hypertrophy.
Pham H; Sharma P
Can J Urol; 2018 Apr; 25(2):9228-9237. PubMed ID: 29679999
[TBL] [Abstract][Full Text] [Related]
40. The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia.
Madersbacher S; Roehrborn CG; Oelke M
BJU Int; 2020 Sep; 126(3):317-326. PubMed ID: 32599656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
